Andrea Guastalla

535 total citations
9 papers, 413 citations indexed

About

Andrea Guastalla is a scholar working on Immunology, Infectious Diseases and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Andrea Guastalla has authored 9 papers receiving a total of 413 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Immunology, 3 papers in Infectious Diseases and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Andrea Guastalla's work include Immunodeficiency and Autoimmune Disorders (3 papers), Systemic Lupus Erythematosus Research (2 papers) and Rheumatoid Arthritis Research and Therapies (2 papers). Andrea Guastalla is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (3 papers), Systemic Lupus Erythematosus Research (2 papers) and Rheumatoid Arthritis Research and Therapies (2 papers). Andrea Guastalla collaborates with scholars based in Italy, United States and Switzerland. Andrea Guastalla's co-authors include Francesca Spanò, Giuseppe Murdaca, Miriam Contatore, Francesco Puppo, Ottavia Magnani, Paola Romagnani, Raffaele De Palma, Simone Negrini, Francesco Guzzi and G. Gnone and has published in prestigious journals such as Journal of Clinical Immunology, Human Vaccines & Immunotherapeutics and Expert Opinion on Drug Metabolism & Toxicology.

In The Last Decade

Andrea Guastalla

8 papers receiving 409 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrea Guastalla Italy 7 151 79 75 64 58 9 413
Meenakshi Sachdeva India 11 136 0.9× 79 1.0× 81 1.1× 84 1.3× 46 0.8× 34 509
Ottavia Magnani Italy 8 211 1.4× 97 1.2× 67 0.9× 56 0.9× 37 0.6× 10 418
Marco Krasselt Germany 12 133 0.9× 190 2.4× 90 1.2× 60 0.9× 74 1.3× 38 488
Nathalie Marchand United States 11 199 1.3× 72 0.9× 52 0.7× 135 2.1× 75 1.3× 16 548
Laurent Gilardin France 11 179 1.2× 44 0.6× 47 0.6× 73 1.1× 114 2.0× 27 454
Anna Felis‐Giemza Poland 10 168 1.1× 163 2.1× 53 0.7× 67 1.0× 52 0.9× 52 474
Alejandro Díaz-Borjón Mexico 9 76 0.5× 88 1.1× 64 0.9× 49 0.8× 72 1.2× 16 366
Alexandra Tsirogianni Greece 10 240 1.6× 144 1.8× 76 1.0× 58 0.9× 93 1.6× 68 455
Mathieu Uzzan France 14 206 1.4× 23 0.3× 151 2.0× 61 1.0× 57 1.0× 33 552
Jaya Goswami United States 7 208 1.4× 24 0.3× 94 1.3× 117 1.8× 50 0.9× 11 431

Countries citing papers authored by Andrea Guastalla

Since Specialization
Citations

This map shows the geographic impact of Andrea Guastalla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Guastalla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Guastalla more than expected).

Fields of papers citing papers by Andrea Guastalla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea Guastalla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Guastalla. The network helps show where Andrea Guastalla may publish in the future.

Co-authorship network of co-authors of Andrea Guastalla

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea Guastalla. A scholar is included among the top collaborators of Andrea Guastalla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea Guastalla. Andrea Guastalla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Contini, Paola, Federico Ivaldi, Ottavia Magnani, et al.. (2024). Evaluation of Frequency of CMV Replication and Disease Complications Reveals New Cellular Defects and a Time Dependent Pattern in CVID Patients. Journal of Clinical Immunology. 44(6). 142–142.
2.
Romagnani, Paola, G. Gnone, Francesco Guzzi, et al.. (2020). The COVID-19 infection: lessons from the Italian experience. Journal of Public Health Policy. 41(3). 238–244. 46 indexed citations
3.
Murdaca, Giuseppe, Francesca Spanò, Miriam Contatore, et al.. (2015). Immunogenicity of infliximab and adalimumab: what is its role in hypersensitivity and modulation of therapeutic efficacy and safety?. Expert Opinion on Drug Safety. 15(1). 43–52. 65 indexed citations
4.
Fenoglio, Daniela, Alessia Parodi, Francesca Kalli, et al.. (2015). Immunogenicity of GX301 cancer vaccine: Four (telomerase peptides) are better than one. Human Vaccines & Immunotherapeutics. 11(4). 838–850. 26 indexed citations
5.
Murdaca, Giuseppe, Francesca Spanò, Miriam Contatore, et al.. (2015). Infection risk associated with anti-TNF-α agents: a review. Expert Opinion on Drug Safety. 14(4). 571–582. 138 indexed citations
6.
Murdaca, Giuseppe, Rodolfo Russo, Francesca Spanò, et al.. (2015). Autoimmune central diabetes insipidus in a patient with ureaplasma urealyticum infection and review on new triggers of immune response. Archives of Endocrinology and Metabolism. 59(6). 554–558. 4 indexed citations
7.
Murdaca, Giuseppe, Francesca Spanò, Miriam Contatore, et al.. (2014). Pharmacogenetics of etanercept: role of TNF-α gene polymorphisms in improving its efficacy. Expert Opinion on Drug Metabolism & Toxicology. 10(12). 1703–1710. 53 indexed citations
8.
Murdaca, Giuseppe, Francesca Spanò, Miriam Contatore, et al.. (2014). Efficacy and safety of etanercept in chronic immune-mediated disease. Expert Opinion on Drug Safety. 13(5). 649–661. 27 indexed citations
9.
Murdaca, Giuseppe, Francesca Spanò, Miriam Contatore, Andrea Guastalla, & Francesco Puppo. (2014). Potential Use of TNF-α Inhibitors in Systemic Sclerosis. Immunotherapy. 6(3). 283–289. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026